- Zacks•2 days ago
Momenta (MNTA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Investopedia•2 days ago
A month has gone by since the last earnings report for Momenta Pharmaceuticals, Inc. MNTA. Shares have lost about 9.6% in that time frame, underperforming the market. Will the recent negative trend continue ...
- PR Newswire•6 days ago
Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander Consumer USA Holdings Inc. and The Interpublic Group of Companies, Inc.
NEW YORK, March 24, 2017 /PRNewswire/ -- Aratana Therapeutics, Inc. (PETX) Lifshitz & Miller announces investigation on behalf of PETX investors concerning PETX's statements about the commercial viability ...
MNTA : Summary for Momenta Pharmaceuticals, Inc. - Yahoo Finance
Momenta Pharmaceuticals, Inc. (MNTA)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Ask||20.00 x 200|
|Day's Range||13.05 - 13.62|
|52 Week Range||8.82 - 19.90|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-43.14|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|